US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bioxcel Therapeutics Inc.

1.26

-0.1100-8.03%

Pre-market: 1.310.0498+3.95%07:16 EDT

Volume:963.35K

Turnover:1.24M

Market Cap:30.87M

PE:-0.14

High:1.42

Open:1.42

Low:1.25

Close:1.37

52wk High:8.08

52wk Low:1.17

Shares:24.50M

Float Shares:22.09M

Volume Ratio:1.73

T/O Rate:4.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.0893

EPS(LYR):-23.5105

ROE:-1766.94%

ROA:-75.47%

PB:-0.32

PE(LYR):-0.05

Loading ...

Overview Company News Filings

Calendar of U.S. Earnings Expected in the Week Ahead

BioXcel Therapeutics to Host Virtual KOL Roundtable on Acute Agitation in Alzheimer’s Dementia

BioXcel Therapeutics Unveils IGALMI At-Home Agitation Treatment Opportunity for Bipolar Disorder and Schizophrenia

BioXcel Therapeutics führt neue Bonusvereinbarungen für Führungskräfte ein

Rigel Pharmaceuticals beruft Michael P. Miller in den Vorstand

BUZZ-BioXcel seeks FDA nod for at‑home agitation treatment; shares fall

BioXcel Therapeutics Submits sNDA to FDA for IGALMI Label Expansion to At-Home Use

BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Igalmi® Label Expansion in the at-Home Setting

THOMSON REUTERS

BioXcel Therapeutics Inc: Submission Timeline Supports Potential Approval of Igalmi Label Expansion as Early as Year-End 2026

THOMSON REUTERS

BioXcel Therapeutics Appoints Mark Pavao as Interim Chief Commercial Officer

BioXcel Therapeutics Inc - to Submit Snda This Month for Igalmi at-Home Use - SEC Filing

THOMSON REUTERS

BioXcel Therapeutics Plans sNDA Submission for IGALMI At-Home Use

BioXcel Therapeutics Plans sNDA Submission Seeking FDA Approval for At-Home Use of IGALMI

BioXcel Therapeutics Planning to Submit Snda This Month Seeking FDA Approval for at-Home Use of Igalmi®

THOMSON REUTERS

BioXcel Therapeutics Inc. held annual shareholder meeting

Analysts Conflicted on These Healthcare Names: Bioxcel Therapeutics (BTAI) and Day One Biopharmaceuticals (DAWN)

BioXcel Therapeutics Q3 revenue misses analyst expectations

BRIEF-BioXcel Therapeutics Q3 Basic EPS USD -2.18 Vs. IBES Estimate USD -1.24

BioXcel Therapeutics Q3 Basic EPS USD -2.18 VS. Ibes Estimate USD -1.24

THOMSON REUTERS

BioXcel Therapeutics Q3 Revenue USD 98 Thousand VS. Ibes Estimate USD 216 Thousand

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BTAI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BTAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BTAI\",,,,,undefined,":{"symbol":"BTAI","market":"US","secType":"STK","nameCN":"Bioxcel Therapeutics Inc.","latestPrice":1.26,"timestamp":1774641600000,"preClose":1.37,"halted":0,"volume":963346,"hourTrading":{"tag":"盘前","latestPrice":1.3098,"preClose":1.26,"latestTime":"07:16 EDT","volume":2234,"amount":2865.9125910000002,"timestamp":1774869391747,"change":0.0498,"changeRate":0.039524,"amplitude":0.031587},"delay":0,"changeRate":-0.08029197080291978,"floatShares":22094200,"shares":24496500,"eps":-9.089346,"marketStatus":"Pre-Mkt","change":-0.11,"latestTime":"03-30 07:21:01 EDT","open":1.42,"high":1.42,"low":1.25,"amount":1243214.1008782,"amplitude":0.124088,"askPrice":1.42,"askSize":200,"bidPrice":1.27,"bidSize":308,"shortable":3,"etf":0,"ttmEps":-9.089346,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774877400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1520485200000,"exchange":"NASDAQ","adjPreClose":1.26,"preHourTrading":{"tag":"盘前","latestPrice":1.3098,"preClose":1.26,"latestTime":"07:16 EDT","volume":2234,"amount":2865.9125910000002,"timestamp":1774869391747,"change":0.0498,"changeRate":0.039524,"amplitude":0.031587},"postHourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"19:56 EDT","volume":7466,"amount":9487.2368,"timestamp":1774655796454,"change":0,"changeRate":0,"amplitude":0.029365},"volumeRatio":1.725378598335708,"impliedVol":0.2625,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BTAI\",,,,,undefined,":{"symbol":"BTAI","floatShares":22094200,"roa":"-75.47%","roe":"-1766.94%","lyrEps":-23.510453,"volumeRatio":1.725378598335708,"shares":24496500,"dividePrice":0,"high":1.42,"amplitude":0.124088,"preClose":1.37,"low":1.25,"week52Low":1.17,"pbRate":"-0.32","psRate":"48.08","week52High":8.08,"institutionHeld":0,"latestPrice":1.26,"committee":0.212598,"eps":-9.089346,"divideRate":0,"volume":963346,"delay":0,"ttmEps":-9.089346,"open":1.42,"prevYearClose":1.6,"prevWeekClose":1.26,"prevMonthClose":1.67,"prevQuarterClose":1.6,"fiveDayClose":1.51,"twentyDayClose":1.67,"sixtyDayClose":1.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BTAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-27","symbol":"BTAI","fiscalQuarterEnding":"2025/12","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1774584000000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2025-11-12","symbol":"BTAI","fiscalQuarterEnding":"2025/09","expectedEps":-1.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-2.18},{"market":"US","date":"2025-08-12","symbol":"BTAI","fiscalQuarterEnding":"2025/06","expectedEps":-2.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-2.45},{"market":"US","date":"2025-05-12","symbol":"BTAI","fiscalQuarterEnding":"2025/03","expectedEps":-2.72,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.5},{"market":"US","date":"2025-03-27","symbol":"BTAI","fiscalQuarterEnding":"2024/12","expectedEps":-4.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-3.57}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BTAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BTAI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.8,"hold":0,"sell":0.2,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1753761600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BTAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BTAI","date":"2026-03-27","current":-0.13563,"percent":0.66747,"low":-12.907167,"twenty":-5.341123,"median":-1.024275,"eighty":-0.297799,"high":-0.075584,"avg":-2.744269,"sd":2.977846,"marketCap":33359205},"quantilePoints":[{"date":"2021-04-01","current":-11.253399,"twenty":-20.758838,"median":-12.561953,"eighty":-6.331584,"marketCap":924680560},{"date":"2021-04-09","current":-10.727064,"twenty":-20.728649,"median":-12.432604,"eighty":-6.378241,"marketCap":881432146},{"date":"2021-04-16","current":-10.476864,"twenty":-20.687139,"median":-12.317081,"eighty":-6.437827,"marketCap":860873476},{"date":"2021-04-23","current":-10.341969,"twenty":-20.622913,"median":-12.292905,"eighty":-6.451056,"marketCap":849789268},{"date":"2021-04-30","current":-10.183093,"twenty":-20.583252,"median":-12.183066,"eighty":-6.459911,"marketCap":836734534},{"date":"2021-05-07","current":-9.148896,"twenty":-20.554865,"median":-12.032854,"eighty":-6.509856,"marketCap":751755607},{"date":"2021-05-14","current":-8.27871,"twenty":-20.518918,"median":-12.003696,"eighty":-6.620208,"marketCap":775168693},{"date":"2021-05-21","current":-8.418135,"twenty":-20.453173,"median":-11.850922,"eighty":-6.772889,"marketCap":788223648},{"date":"2021-05-28","current":-8.689094,"twenty":-20.396568,"median":-11.727247,"eighty":-6.913691,"marketCap":813594596},{"date":"2021-06-04","current":-9.196812,"twenty":-20.389363,"median":-11.675065,"eighty":-6.970815,"marketCap":861134335},{"date":"2021-06-11","current":-9.959706,"twenty":-20.3602,"median":-11.515521,"eighty":-7.018081,"marketCap":932567103},{"date":"2021-06-18","current":-9.941291,"twenty":-20.355379,"median":-11.354209,"eighty":-7.04643,"marketCap":930842864},{"date":"2021-06-25","current":-9.223355,"twenty":-20.3371,"median":-11.302252,"eighty":-7.107214,"marketCap":863619618},{"date":"2021-07-02","current":-8.300426,"twenty":-20.317699,"median":-11.253399,"eighty":-7.191924,"marketCap":777202082},{"date":"2021-07-09","current":-8.297458,"twenty":-20.311661,"median":-11.233521,"eighty":-7.214514,"marketCap":776924212},{"date":"2021-07-16","current":-8.068952,"twenty":-20.302227,"median":-11.181625,"eighty":-7.285106,"marketCap":755528230},{"date":"2021-07-23","current":-7.377497,"twenty":-20.302227,"median":-11.0725,"eighty":-7.299225,"marketCap":690784546},{"date":"2021-07-30","current":-7.594133,"twenty":-20.289983,"median":-11.050676,"eighty":-7.299225,"marketCap":711069048},{"date":"2021-08-06","current":-7.775158,"twenty":-20.275433,"median":-11.028851,"eighty":-7.30854,"marketCap":728019111},{"date":"2021-08-13","current":-6.88901,"twenty":-20.226754,"median":-10.9362,"eighty":-7.214514,"marketCap":687757414},{"date":"2021-08-20","current":-6.79936,"twenty":-20.21378,"median":-10.839701,"eighty":-7.152356,"marketCap":678807338},{"date":"2021-08-27","current":-7.875155,"twenty":-20.198311,"median":-10.779276,"eighty":-7.152356,"marketCap":786208252},{"date":"2021-09-03","current":-8.174921,"twenty":-20.177467,"median":-10.727064,"eighty":-7.186277,"marketCap":816135069},{"date":"2021-09-10","current":-8.247761,"twenty":-20.160791,"median":-10.592353,"eighty":-7.189685,"marketCap":823407006},{"date":"2021-09-17","current":-8.600757,"twenty":-20.139947,"median":-10.523516,"eighty":-7.209299,"marketCap":858647931},{"date":"2021-09-24","current":-8.595153,"twenty":-20.132443,"median":-10.491853,"eighty":-7.214409,"marketCap":858088551},{"date":"2021-10-01","current":-8.603558,"twenty":-20.064907,"median":-10.476864,"eighty":-7.243231,"marketCap":858927621},{"date":"2021-10-08","current":-8.56994,"twenty":-20.044896,"median":-10.416911,"eighty":-7.278167,"marketCap":855571342},{"date":"2021-10-15","current":-7.589397,"twenty":-20.024372,"median":-10.358075,"eighty":-7.296401,"marketCap":757679884},{"date":"2021-10-22","current":-8.387839,"twenty":-20.019128,"median":-10.308995,"eighty":-7.306677,"marketCap":837391500},{"date":"2021-10-29","current":-8.163715,"twenty":-19.92803,"median":-10.209478,"eighty":-7.312382,"marketCap":815016310},{"date":"2021-11-05","current":-9.592505,"twenty":-19.890755,"median":-10.183093,"eighty":-7.358522,"marketCap":957658149},{"date":"2021-11-12","current":-9.48221,"twenty":-19.887125,"median":-10.075455,"eighty":-7.375417,"marketCap":966161312},{"date":"2021-11-19","current":-6.980532,"twenty":-19.884335,"median":-9.966705,"eighty":-7.312382,"marketCap":711260369},{"date":"2021-11-26","current":-6.200646,"twenty":-19.870263,"median":-9.949183,"eighty":-7.281907,"marketCap":631796190},{"date":"2021-12-03","current":-5.893085,"twenty":-19.857352,"median":-9.934768,"eighty":-7.204609,"marketCap":600458203},{"date":"2021-12-10","current":-6.000182,"twenty":-19.848143,"median":-9.906547,"eighty":-7.097817,"marketCap":611370538},{"date":"2021-12-17","current":-6.123755,"twenty":-19.833879,"median":-9.872898,"eighty":-6.982771,"marketCap":623961693},{"date":"2021-12-23","current":-6.250075,"twenty":-19.742233,"median":-9.857792,"eighty":-6.885243,"marketCap":636832652},{"date":"2021-12-31","current":-5.582778,"twenty":-19.598097,"median":-9.844099,"eighty":-6.774146,"marketCap":568840413},{"date":"2022-01-07","current":-5.412521,"twenty":-19.555399,"median":-9.824143,"eighty":-6.667102,"marketCap":551492599},{"date":"2022-01-14","current":-5.354853,"twenty":-19.528629,"median":-9.781651,"eighty":-6.538413,"marketCap":545616727},{"date":"2022-01-21","current":-4.580459,"twenty":-19.525826,"median":-9.694009,"eighty":-6.450701,"marketCap":466712154},{"date":"2022-01-28","current":-4.281137,"twenty":-19.506094,"median":-9.619374,"eighty":-6.317198,"marketCap":436213578},{"date":"2022-02-04","current":-4.300359,"twenty":-19.470536,"median":-9.561688,"eighty":-6.269377,"marketCap":438172202},{"date":"2022-02-11","current":-4.866051,"twenty":-19.46269,"median":-9.506227,"eighty":-6.227372,"marketCap":495811713},{"date":"2022-02-18","current":-4.618904,"twenty":-19.449928,"median":-9.48221,"eighty":-6.124854,"marketCap":470629402},{"date":"2022-02-25","current":-4.962164,"twenty":-19.429196,"median":-9.463733,"eighty":-6.107279,"marketCap":505604834},{"date":"2022-03-04","current":-4.555745,"twenty":-19.415697,"median":-9.395125,"eighty":-6.073524,"marketCap":464193923},{"date":"2022-03-11","current":-4.532077,"twenty":-19.396551,"median":-9.349077,"eighty":-6.038627,"marketCap":484619575},{"date":"2022-03-18","current":-4.621044,"twenty":-19.393714,"median":-9.299246,"eighty":-5.997436,"marketCap":494132892},{"date":"2022-03-25","current":-5.746214,"twenty":-19.377038,"median":-9.253759,"eighty":-5.966837,"marketCap":614448376},{"date":"2022-04-01","current":-5.63893,"twenty":-19.376494,"median":-9.223623,"eighty":-5.919017,"marketCap":602976434},{"date":"2022-04-08","current":-4.477127,"twenty":-19.344873,"median":-9.196812,"eighty":-5.881824,"marketCap":478743702},{"date":"2022-04-14","current":-4.076776,"twenty":-19.325837,"median":-9.148896,"eighty":-5.843734,"marketCap":435933775},{"date":"2022-04-22","current":-3.579609,"twenty":-19.309196,"median":-9.119073,"eighty":-5.77521,"marketCap":382771119},{"date":"2022-04-29","current":-3.430458,"twenty":-19.297794,"median":-9.093709,"eighty":-5.740416,"marketCap":366822322},{"date":"2022-05-06","current":-3.286541,"twenty":-19.293358,"median":-9.077475,"eighty":-5.708502,"marketCap":351433133},{"date":"2022-05-13","current":-2.932736,"twenty":-19.289482,"median":-9.043401,"eighty":-5.671836,"marketCap":328545602},{"date":"2022-05-20","current":-3.389883,"twenty":-19.27932,"median":-9.010461,"eighty":-5.635438,"marketCap":379758417},{"date":"2022-05-27","current":-3.060138,"twenty":-19.235731,"median":-9.000731,"eighty":-5.584169,"marketCap":342818026},{"date":"2022-06-03","current":-2.790346,"twenty":-19.214888,"median":-8.893818,"eighty":-5.547086,"marketCap":312594069},{"date":"2022-06-10","current":-2.563021,"twenty":-19.151264,"median":-8.868016,"eighty":-5.529706,"marketCap":287127587},{"date":"2022-06-17","current":-2.580508,"twenty":-19.111096,"median":-8.841332,"eighty":-5.458772,"marketCap":289086547},{"date":"2022-06-24","current":-3.025165,"twenty":-19.10053,"median":-8.830484,"eighty":-5.439433,"marketCap":338900105},{"date":"2022-07-01","current":-3.564748,"twenty":-19.080598,"median":-8.812395,"eighty":-5.402564,"marketCap":399348019},{"date":"2022-07-08","current":-4.049374,"twenty":-19.067868,"median":-8.774902,"eighty":-5.364662,"marketCap":453639200},{"date":"2022-07-15","current":-4.20925,"twenty":-19.054365,"median":-8.739355,"eighty":-5.335491,"marketCap":471549693},{"date":"2022-07-22","current":-3.959443,"twenty":-19.045767,"median":-8.692552,"eighty":-5.283453,"marketCap":443564548},{"date":"2022-07-29","current":-3.857022,"twenty":-19.036648,"median":-8.681202,"eighty":-5.201946,"marketCap":432090638},{"date":"2022-08-05","current":-4.099335,"twenty":-19.026333,"median":-8.636548,"eighty":-5.1768,"marketCap":459236229},{"date":"2022-08-12","current":-3.590093,"twenty":-19.001261,"median":-8.623896,"eighty":-5.101853,"marketCap":438271352},{"date":"2022-08-19","current":-3.314638,"twenty":-18.973288,"median":-8.609161,"eighty":-5.040968,"marketCap":404644394},{"date":"2022-08-26","current":-3.153956,"twenty":-18.960428,"median":-8.595153,"eighty":-5.026382,"marketCap":385028669},{"date":"2022-09-02","current":-3.229706,"twenty":-18.95028,"median":-8.584677,"eighty":-4.986434,"marketCap":394276082},{"date":"2022-09-09","current":-3.351365,"twenty":-18.944157,"median":-8.576943,"eighty":-4.953378,"marketCap":409127989},{"date":"2022-09-16","current":-2.885388,"twenty":-18.933804,"median":-8.565041,"eighty":-4.932428,"marketCap":352242385},{"date":"2022-09-23","current":-2.648956,"twenty":-18.93029,"median":-8.528219,"eighty":-4.904497,"marketCap":323379246},{"date":"2022-09-30","current":-2.713229,"twenty":-18.898026,"median":-8.505504,"eighty":-4.846829,"marketCap":331225536},{"date":"2022-10-07","current":-2.547956,"twenty":-18.860022,"median":-8.495466,"eighty":-4.830352,"marketCap":311049361},{"date":"2022-10-14","current":-2.352842,"twenty":-18.849372,"median":-8.490353,"eighty":-4.786415,"marketCap":287230266},{"date":"2022-10-21","current":-2.476797,"twenty":-18.835428,"median":-8.461538,"eighty":-4.723255,"marketCap":302362397},{"date":"2022-10-28","current":-2.899161,"twenty":-18.798724,"median":-8.422299,"eighty":-4.643871,"marketCap":353923732},{"date":"2022-11-04","current":-2.690274,"twenty":-18.779213,"median":-8.416994,"eighty":-4.629889,"marketCap":328423289},{"date":"2022-11-11","current":-3.236176,"twenty":-18.760041,"median":-8.409862,"eighty":-4.59408,"marketCap":443595620},{"date":"2022-11-18","current":-3.105423,"twenty":-18.747535,"median":-8.380835,"eighty":-4.555745,"marketCap":425672787},{"date":"2022-11-25","current":-3.191287,"twenty":-18.737529,"median":-8.351893,"eighty":-4.504871,"marketCap":437442542},{"date":"2022-12-02","current":-3.706473,"twenty":-18.675558,"median":-8.341003,"eighty":-4.415505,"marketCap":508061069},{"date":"2022-12-09","current":-3.479546,"twenty":-18.6305,"median":-8.331654,"eighty":-4.345395,"marketCap":476955289},{"date":"2022-12-16","current":-4.098995,"twenty":-18.605889,"median":-8.323403,"eighty":-4.271217,"marketCap":561865661},{"date":"2022-12-23","current":-4.491517,"twenty":-18.56943,"median":-8.314138,"eighty":-4.267409,"marketCap":615670253},{"date":"2022-12-30","current":-4.391342,"twenty":-18.553041,"median":-8.299706,"eighty":-4.270731,"marketCap":601938873},{"date":"2023-01-06","current":-4.601914,"twenty":-18.536176,"median":-8.295853,"eighty":-4.275476,"marketCap":630802794},{"date":"2023-01-13","current":-5.916455,"twenty":-18.512161,"median":-8.284096,"eighty":-4.288826,"marketCap":810992131},{"date":"2023-01-20","current":-6.194491,"twenty":-18.499431,"median":-8.28262,"eighty":-4.303427,"marketCap":849103717},{"date":"2023-01-27","current":-6.472528,"twenty":-18.490876,"median":-8.269143,"eighty":-4.315927,"marketCap":887215303},{"date":"2023-02-03","current":-6.210847,"twenty":-18.489518,"median":-8.247761,"eighty":-4.322333,"marketCap":851345575},{"date":"2023-02-10","current":-6.773053,"twenty":-18.479167,"median":-8.233107,"eighty":-4.345549,"marketCap":928409444},{"date":"2023-02-17","current":-6.611546,"twenty":-18.458736,"median":-8.176114,"eighty":-4.350871,"marketCap":906271096},{"date":"2023-02-24","current":-6.037074,"twenty":-18.455712,"median":-8.174921,"eighty":-4.352535,"marketCap":827525834},{"date":"2023-03-03","current":-6.182225,"twenty":-18.445012,"median":-8.167369,"eighty":-4.364131,"marketCap":847422324},{"date":"2023-03-10","current":-3.492823,"twenty":-18.237642,"median":-8.147964,"eighty":-4.351703,"marketCap":578959828},{"date":"2023-03-17","current":-3.398741,"twenty":-18.047626,"median":-8.068952,"eighty":-4.29267,"marketCap":563365189},{"date":"2023-03-24","current":-3.206228,"twenty":-17.95461,"median":-8.038882,"eighty":-4.227497,"marketCap":531454699},{"date":"2023-03-31","current":-3.265732,"twenty":-17.876582,"median":-8.003763,"eighty":-4.208799,"marketCap":541317941},{"date":"2023-04-06","current":-2.985712,"twenty":-17.781403,"median":-7.981738,"eighty":-4.159863,"marketCap":494902684},{"date":"2023-04-14","current":-3.349738,"twenty":-17.69101,"median":-7.932562,"eighty":-4.119975,"marketCap":555242519},{"date":"2023-04-21","current":-3.701513,"twenty":-17.526694,"median":-7.875736,"eighty":-4.092862,"marketCap":613551686},{"date":"2023-04-28","current":-3.607006,"twenty":-17.370102,"median":-7.82875,"eighty":-4.073925,"marketCap":597886536},{"date":"2023-05-05","current":-3.971032,"twenty":-17.228301,"median":-7.773544,"eighty":-4.019732,"marketCap":658226371},{"date":"2023-05-12","current":-4.197584,"twenty":-17.132362,"median":-7.765133,"eighty":-4.019732,"marketCap":785288139},{"date":"2023-05-19","current":-4.135135,"twenty":-17.038021,"median":-7.736896,"eighty":-4.019732,"marketCap":773605196},{"date":"2023-05-26","current":-3.011338,"twenty":-16.914292,"median":-7.72182,"eighty":-4.00749,"marketCap":563364206},{"date":"2023-06-02","current":-2.828975,"twenty":-16.784295,"median":-7.712188,"eighty":-3.968298,"marketCap":529247429},{"date":"2023-06-09","current":-3.179674,"twenty":-16.58895,"median":-7.69454,"eighty":-3.946453,"marketCap":594856615},{"date":"2023-06-16","current":-3.351127,"twenty":-16.373858,"median":-7.687481,"eighty":-3.90696,"marketCap":626932217},{"date":"2023-06-23","current":-2.959903,"twenty":-16.274147,"median":-7.666303,"eighty":-3.878276,"marketCap":553741525},{"date":"2023-06-30","current":-0.995986,"twenty":-16.233994,"median":-7.631008,"eighty":-3.856568,"marketCap":186330086},{"date":"2023-07-07","current":-1.695826,"twenty":-15.980425,"median":-7.602771,"eighty":-3.818644,"marketCap":317256861},{"date":"2023-07-14","current":-1.775318,"twenty":-15.670542,"median":-7.591826,"eighty":-3.783112,"marketCap":332128276},{"date":"2023-07-21","current":-1.750379,"twenty":-15.533519,"median":-7.567475,"eighty":-3.753808,"marketCap":327462734},{"date":"2023-07-28","current":-1.482289,"twenty":-14.995263,"median":-7.547374,"eighty":-3.704487,"marketCap":277308157},{"date":"2023-08-04","current":-1.203288,"twenty":-14.584599,"median":-7.482764,"eighty":-3.674961,"marketCap":225112405},{"date":"2023-08-11","current":-1.151853,"twenty":-14.413652,"median":-7.440409,"eighty":-3.656953,"marketCap":215489724},{"date":"2023-08-18","current":-0.63171,"twenty":-14.413652,"median":-7.405113,"eighty":-3.629458,"marketCap":128190322},{"date":"2023-08-25","current":-0.56176,"twenty":-14.451968,"median":-7.373317,"eighty":-3.604961,"marketCap":113995732},{"date":"2023-09-01","current":-0.545174,"twenty":-14.451968,"median":-7.281108,"eighty":-3.573665,"marketCap":110630004},{"date":"2023-09-08","current":-0.493253,"twenty":-14.355672,"median":-7.202263,"eighty":-3.535658,"marketCap":100093813},{"date":"2023-09-15","current":-0.491811,"twenty":-14.355672,"median":-7.061812,"eighty":-3.506216,"marketCap":99801141},{"date":"2023-09-22","current":-0.435562,"twenty":-14.355672,"median":-6.92457,"eighty":-3.479923,"marketCap":88386934},{"date":"2023-09-29","current":-0.359123,"twenty":-14.355672,"median":-6.797451,"eighty":-3.444632,"marketCap":72875320},{"date":"2023-10-06","current":-0.379314,"twenty":-14.426087,"median":-6.695703,"eighty":-3.431215,"marketCap":76972728},{"date":"2023-10-13","current":-0.432678,"twenty":-14.426087,"median":-6.659241,"eighty":-3.406518,"marketCap":87801591},{"date":"2023-10-20","current":-0.373545,"twenty":-14.426087,"median":-6.56724,"eighty":-3.381455,"marketCap":75802040},{"date":"2023-10-27","current":-0.432678,"twenty":-14.567515,"median":-6.538502,"eighty":-3.35895,"marketCap":87801591},{"date":"2023-11-03","current":-0.575462,"twenty":-14.567515,"median":-6.472064,"eighty":-3.341914,"marketCap":116776116},{"date":"2023-11-10","current":-0.682189,"twenty":-14.567515,"median":-6.396828,"eighty":-3.320055,"marketCap":138433841},{"date":"2023-11-17","current":-0.58793,"twenty":-14.567515,"median":-6.396828,"eighty":-3.314434,"marketCap":124408851},{"date":"2023-11-24","current":-0.543662,"twenty":-14.567515,"median":-6.396828,"eighty":-3.296256,"marketCap":115041597},{"date":"2023-12-01","current":-0.525678,"twenty":-14.567515,"median":-6.396828,"eighty":-3.27845,"marketCap":111236149},{"date":"2023-12-08","current":-0.484177,"twenty":-14.566917,"median":-6.364176,"eighty":-3.262841,"marketCap":102454348},{"date":"2023-12-15","current":-0.44821,"twenty":-14.566917,"median":-6.364176,"eighty":-3.225115,"marketCap":94843454},{"date":"2023-12-22","current":-0.410859,"twenty":-14.566917,"median":-6.364176,"eighty":-3.207524,"marketCap":86939832},{"date":"2023-12-29","current":-0.415009,"twenty":-14.567515,"median":-6.396828,"eighty":-3.205905,"marketCap":87818013},{"date":"2024-01-05","current":-0.387342,"twenty":-14.568113,"median":-6.42948,"eighty":-3.192901,"marketCap":81963478},{"date":"2024-01-12","current":-0.370742,"twenty":-14.568113,"median":-6.327377,"eighty":-3.160117,"marketCap":78450758},{"date":"2024-01-19","current":-0.359265,"twenty":-14.568711,"median":-6.330444,"eighty":-3.138953,"marketCap":76022192},{"date":"2024-01-26","current":-0.465347,"twenty":-14.568113,"median":-6.327377,"eighty":-3.125722,"marketCap":98469690},{"date":"2024-02-02","current":-0.449788,"twenty":-14.568113,"median":-6.327377,"eighty":-3.097458,"marketCap":95177390},{"date":"2024-02-09","current":-0.538419,"twenty":-14.568113,"median":-6.286489,"eighty":-3.03805,"marketCap":113932140},{"date":"2024-02-16","current":-0.515446,"twenty":-14.568113,"median":-6.239468,"eighty":-3.02044,"marketCap":109071035},{"date":"2024-02-23","current":-0.455143,"twenty":-14.568113,"median":-6.1979,"eighty":-3.008421,"marketCap":96310635},{"date":"2024-03-01","current":-0.456579,"twenty":-14.567515,"median":-6.149515,"eighty":-2.982732,"marketCap":96614454},{"date":"2024-03-08","current":-0.436478,"twenty":-14.567515,"median":-6.093549,"eighty":-2.940264,"marketCap":92360988},{"date":"2024-03-15","current":-0.486985,"twenty":-14.567515,"median":-6.03785,"eighty":-2.923516,"marketCap":87196064},{"date":"2024-03-22","current":-0.480197,"twenty":-14.567515,"median":-5.998481,"eighty":-2.897325,"marketCap":85980788},{"date":"2024-03-28","current":-0.491814,"twenty":-14.567515,"median":-5.951356,"eighty":-2.876482,"marketCap":88060812},{"date":"2024-04-05","current":-0.459368,"twenty":-14.568113,"median":-5.86837,"eighty":-2.834275,"marketCap":82251244},{"date":"2024-04-12","current":-0.476445,"twenty":-14.568113,"median":-5.822413,"eighty":-2.809293,"marketCap":85308912},{"date":"2024-04-19","current":-0.527431,"twenty":-14.568113,"median":-5.753035,"eighty":-2.797201,"marketCap":94438018},{"date":"2024-04-26","current":-0.539841,"twenty":-14.567515,"median":-5.715607,"eighty":-2.765565,"marketCap":96660089},{"date":"2024-05-03","current":-0.529499,"twenty":-14.567515,"median":-5.666243,"eighty":-2.740784,"marketCap":94808363},{"date":"2024-05-10","current":-0.565238,"twenty":-14.567515,"median":-5.584105,"eighty":-2.701389,"marketCap":86508542},{"date":"2024-05-17","current":-0.512515,"twenty":-14.567515,"median":-5.52894,"eighty":-2.689815,"marketCap":78439415},{"date":"2024-05-24","current":-0.453662,"twenty":-14.567515,"median":-5.452123,"eighty":-2.677462,"marketCap":69432018},{"date":"2024-05-31","current":-0.443853,"twenty":-14.567515,"median":-5.400125,"eighty":-2.647745,"marketCap":67930776},{"date":"2024-06-07","current":-0.34699,"twenty":-14.567515,"median":-5.330699,"eighty":-2.582012,"marketCap":53106104},{"date":"2024-06-14","current":-0.335955,"twenty":-14.567515,"median":-5.201946,"eighty":-2.519951,"marketCap":51417217},{"date":"2024-06-21","current":-0.279554,"twenty":-14.568113,"median":-5.174164,"eighty":-2.476165,"marketCap":42785130},{"date":"2024-06-28","current":-0.313885,"twenty":-14.568113,"median":-5.054629,"eighty":-2.408393,"marketCap":48039444},{"date":"2024-07-05","current":-0.257484,"twenty":-14.568113,"median":-5.022578,"eighty":-2.303222,"marketCap":39407356},{"date":"2024-07-12","current":-0.296719,"twenty":-14.568113,"median":-4.962164,"eighty":-1.768148,"marketCap":45412287},{"date":"2024-07-19","current":-0.28691,"twenty":-14.568113,"median":-4.922049,"eighty":-1.702373,"marketCap":43911054},{"date":"2024-07-26","current":-0.282006,"twenty":-14.568113,"median":-4.866051,"eighty":-1.600436,"marketCap":43160438},{"date":"2024-08-02","current":-0.24277,"twenty":-14.568113,"median":-4.830352,"eighty":-1.459221,"marketCap":37155507},{"date":"2024-08-09","current":-0.276242,"twenty":-14.568113,"median":-4.786415,"eighty":-1.190196,"marketCap":29787762},{"date":"2024-08-16","current":-0.254365,"twenty":-14.568113,"median":-4.723255,"eighty":-1.147489,"marketCap":27428699},{"date":"2024-08-23","current":-0.256557,"twenty":-14.568113,"median":-4.638127,"eighty":-0.72661,"marketCap":27665013},{"date":"2024-08-30","current":-0.232375,"twenty":-14.568113,"median":-4.601914,"eighty":-0.654786,"marketCap":25057412},{"date":"2024-09-06","current":-0.206454,"twenty":-14.568113,"median":-4.585559,"eighty":-0.620419,"marketCap":22262390},{"date":"2024-09-13","current":-0.256934,"twenty":-14.568113,"median":-4.546716,"eighty":-0.588861,"marketCap":27705756},{"date":"2024-09-20","current":-0.217865,"twenty":-14.568113,"median":-4.477127,"eighty":-0.577625,"marketCap":23492852},{"date":"2024-09-27","current":-0.227803,"twenty":-14.568113,"median":-4.409094,"eighty":-0.569335,"marketCap":24564412},{"date":"2024-10-04","current":-0.220964,"twenty":-14.568113,"median":-4.391342,"eighty":-0.561266,"marketCap":23826950},{"date":"2024-10-11","current":-0.198935,"twenty":-14.568113,"median":-4.391342,"eighty":-0.544695,"marketCap":21451589},{"date":"2024-10-18","current":-0.213785,"twenty":-14.568113,"median":-4.391342,"eighty":-0.539709,"marketCap":23052819},{"date":"2024-10-25","current":-0.230712,"twenty":-14.568113,"median":-4.391342,"eighty":-0.537202,"marketCap":24878139},{"date":"2024-11-01","current":-0.242992,"twenty":-14.568113,"median":-4.391342,"eighty":-0.530658,"marketCap":26202312},{"date":"2024-11-08","current":-0.256934,"twenty":-14.568113,"median":-4.391342,"eighty":-0.525552,"marketCap":27705756},{"date":"2024-11-15","current":-0.342187,"twenty":-14.568113,"median":-4.391342,"eighty":-0.517673,"marketCap":24293888},{"date":"2024-11-22","current":-0.306481,"twenty":-14.568113,"median":-4.391342,"eighty":-0.510553,"marketCap":21758911},{"date":"2024-11-29","current":-0.278325,"twenty":-14.568113,"median":-4.391342,"eighty":-0.504679,"marketCap":19759971},{"date":"2024-12-06","current":-0.277712,"twenty":-14.568113,"median":-4.391342,"eighty":-0.493111,"marketCap":19716457},{"date":"2024-12-13","current":-0.280641,"twenty":-14.568113,"median":-4.391342,"eighty":-0.488033,"marketCap":19924355},{"date":"2024-12-20","current":-0.238372,"twenty":-14.568113,"median":-4.350455,"eighty":-0.485697,"marketCap":16923469},{"date":"2024-12-27","current":-0.275281,"twenty":-14.568113,"median":-4.300359,"eighty":-0.482078,"marketCap":19543878},{"date":"2025-01-03","current":-0.289402,"twenty":-14.568113,"median":-4.259943,"eighty":-0.48105,"marketCap":20546382},{"date":"2025-01-10","current":-0.263747,"twenty":-14.568711,"median":-4.220236,"eighty":-0.476539,"marketCap":18725000},{"date":"2025-01-17","current":-0.240469,"twenty":-14.568711,"median":-4.192077,"eighty":-0.468706,"marketCap":17072356},{"date":"2025-01-24","current":-0.237673,"twenty":-14.568711,"median":-4.143465,"eighty":-0.46289,"marketCap":16873840},{"date":"2025-01-31","current":-0.227887,"twenty":-14.568711,"median":-4.099165,"eighty":-0.4563,"marketCap":16179035},{"date":"2025-02-07","current":-0.115341,"twenty":-14.568711,"median":-4.065907,"eighty":-0.454445,"marketCap":8188775},{"date":"2025-02-14","current":-0.100924,"twenty":-14.568711,"median":-4.028488,"eighty":-0.45083,"marketCap":7165178},{"date":"2025-02-21","current":-0.09306,"twenty":-14.00912,"median":-3.965237,"eighty":-0.449122,"marketCap":6606853},{"date":"2025-02-28","current":-0.09437,"twenty":-13.519531,"median":-3.93583,"eighty":-0.446242,"marketCap":6699907},{"date":"2025-03-07","current":-0.161105,"twenty":-12.701756,"median":-3.878276,"eighty":-0.441493,"marketCap":11437790},{"date":"2025-03-14","current":-0.101826,"twenty":-12.316075,"median":-3.829136,"eighty":-0.438526,"marketCap":7229226},{"date":"2025-03-21","current":-0.111387,"twenty":-12.316075,"median":-3.775982,"eighty":-0.435904,"marketCap":7908026},{"date":"2025-03-28","current":-0.195144,"twenty":-12.068958,"median":-3.724625,"eighty":-0.432705,"marketCap":11630400},{"date":"2025-04-04","current":-0.149548,"twenty":-11.215718,"median":-3.690118,"eighty":-0.420757,"marketCap":8912901},{"date":"2025-04-11","current":-0.166062,"twenty":-10.584929,"median":-3.670136,"eighty":-0.414659,"marketCap":9897148},{"date":"2025-04-17","current":-0.15964,"twenty":-10.476864,"median":-3.646134,"eighty":-0.407036,"marketCap":9514386},{"date":"2025-04-25","current":-0.171567,"twenty":-10.341969,"median":-3.607006,"eighty":-0.399713,"marketCap":10225231},{"date":"2025-05-02","current":-0.16331,"twenty":-10.199879,"median":-3.547261,"eighty":-0.391341,"marketCap":9733107},{"date":"2025-05-09","current":-0.140373,"twenty":-9.957601,"median":-3.482206,"eighty":-0.383469,"marketCap":8366098},{"date":"2025-05-16","current":-0.219192,"twenty":-9.848807,"median":-3.442342,"eighty":-0.372304,"marketCap":8781266},{"date":"2025-05-23","current":-0.207099,"twenty":-9.68296,"median":-3.413343,"eighty":-0.363045,"marketCap":8296783},{"date":"2025-05-30","current":-0.185935,"twenty":-9.516654,"median":-3.388241,"eighty":-0.359151,"marketCap":7448936},{"date":"2025-06-06","current":-0.231285,"twenty":-9.274753,"median":-3.351127,"eighty":-0.353372,"marketCap":9265750},{"date":"2025-06-13","current":-0.267565,"twenty":-9.160886,"median":-3.330706,"eighty":-0.347438,"marketCap":10719201},{"date":"2025-06-20","current":-0.261519,"twenty":-9.043401,"median":-3.316885,"eighty":-0.342187,"marketCap":10476959},{"date":"2025-06-27","current":-0.306869,"twenty":-8.862718,"median":-3.304091,"eighty":-0.326146,"marketCap":12293773},{"date":"2025-07-03","current":-0.291752,"twenty":-8.782857,"median":-3.283374,"eighty":-0.315848,"marketCap":11688168},{"date":"2025-07-11","current":-0.302334,"twenty":-8.631574,"median":-3.264787,"eighty":-0.309908,"marketCap":12112092},{"date":"2025-07-18","current":-0.293264,"twenty":-8.600757,"median":-3.227411,"eighty":-0.305357,"marketCap":11748729},{"date":"2025-07-25","current":-0.261519,"twenty":-8.56994,"median":-3.204084,"eighty":-0.301578,"marketCap":10476959},{"date":"2025-08-01","current":-0.198029,"twenty":-8.490353,"median":-3.174933,"eighty":-0.297799,"marketCap":7933420},{"date":"2025-08-08","current":-0.515479,"twenty":-8.387839,"median":-3.140446,"eighty":-0.297799,"marketCap":20651116},{"date":"2025-08-15","current":-1.357106,"twenty":-8.333954,"median":-3.124847,"eighty":-0.297799,"marketCap":69144529},{"date":"2025-08-22","current":-1.494245,"twenty":-8.297458,"median":-3.097392,"eighty":-0.297799,"marketCap":76131765},{"date":"2025-08-29","current":-1.171396,"twenty":-8.250563,"median":-3.03662,"eighty":-0.297799,"marketCap":59682646},{"date":"2025-09-05","current":-1.019972,"twenty":-8.175852,"median":-3.023808,"eighty":-0.297583,"marketCap":51967572},{"date":"2025-09-12","current":-0.968545,"twenty":-8.163715,"median":-3.008192,"eighty":-0.297799,"marketCap":49347358},{"date":"2025-09-19","current":-1.160684,"twenty":-8.04605,"median":-2.96111,"eighty":-0.297799,"marketCap":59136871},{"date":"2025-09-26","current":-1.087419,"twenty":-7.997228,"median":-2.930869,"eighty":-0.297799,"marketCap":55403978},{"date":"2025-10-03","current":-1.018009,"twenty":-7.894766,"median":-2.903752,"eighty":-0.297799,"marketCap":51867554},{"date":"2025-10-10","current":-1.071994,"twenty":-7.775158,"median":-2.869035,"eighty":-0.297799,"marketCap":54618106},{"date":"2025-10-17","current":-0.948599,"twenty":-7.698,"median":-2.820454,"eighty":-0.297799,"marketCap":48331130},{"date":"2025-10-24","current":-0.871477,"twenty":-7.564457,"median":-2.800397,"eighty":-0.297799,"marketCap":44401770},{"date":"2025-10-31","current":-0.778931,"twenty":-7.416076,"median":-2.764876,"eighty":-0.297799,"marketCap":39686538},{"date":"2025-11-07","current":-0.686385,"twenty":-7.190537,"median":-2.735777,"eighty":-0.297799,"marketCap":34971305},{"date":"2025-11-14","current":-0.687787,"twenty":-6.88901,"median":-2.695041,"eighty":-0.297799,"marketCap":35042741},{"date":"2025-11-21","current":-0.573901,"twenty":-6.773053,"median":-2.684508,"eighty":-0.297799,"marketCap":39146388},{"date":"2025-11-28","current":-0.721384,"twenty":-6.679011,"median":-2.643217,"eighty":-0.297799,"marketCap":49206354},{"date":"2025-12-05","current":-0.670086,"twenty":-6.648345,"median":-2.574561,"eighty":-0.297799,"marketCap":45707236},{"date":"2025-12-12","current":-0.663674,"twenty":-6.544082,"median":-2.508933,"eighty":-0.297799,"marketCap":45269846},{"date":"2025-12-19","current":-0.586726,"twenty":-6.472528,"median":-2.439329,"eighty":-0.297799,"marketCap":40021168},{"date":"2025-12-26","current":-0.548252,"twenty":-6.296758,"median":-2.364319,"eighty":-0.297799,"marketCap":37396829},{"date":"2026-01-02","current":-0.512984,"twenty":-6.250075,"median":-2.051388,"eighty":-0.297799,"marketCap":34991185},{"date":"2026-01-09","current":-0.641231,"twenty":-6.1979,"median":-1.74882,"eighty":-0.297799,"marketCap":43738982},{"date":"2026-01-16","current":-0.612375,"twenty":-6.137249,"median":-1.659198,"eighty":-0.297799,"marketCap":41770727},{"date":"2026-01-23","current":-0.580314,"twenty":-6.107279,"median":-1.60269,"eighty":-0.297799,"marketCap":39583778},{"date":"2026-01-30","current":-0.519397,"twenty":-6.037074,"median":-1.531386,"eighty":-0.297799,"marketCap":35428575},{"date":"2026-02-06","current":-0.439243,"twenty":-5.986452,"median":-1.457102,"eighty":-0.297799,"marketCap":29961202},{"date":"2026-02-13","current":-0.493748,"twenty":-5.86837,"median":-1.292666,"eighty":-0.297799,"marketCap":33679016},{"date":"2026-02-20","current":-0.519397,"twenty":-5.822413,"median":-1.21546,"eighty":-0.297799,"marketCap":35428575},{"date":"2026-02-27","current":-0.564283,"twenty":-5.753035,"median":-1.164841,"eighty":-0.297799,"marketCap":38490304},{"date":"2026-03-06","current":-0.516191,"twenty":-5.675564,"median":-1.152972,"eighty":-0.297799,"marketCap":35209880},{"date":"2026-03-13","current":-0.609676,"twenty":-5.541587,"median":-1.102843,"eighty":-0.297799,"marketCap":41586622},{"date":"2026-03-20","current":-0.571164,"twenty":-5.437236,"median":-1.067672,"eighty":-0.297799,"marketCap":38959656},{"date":"2026-03-27","current":-0.489059,"twenty":-5.341123,"median":-1.024275,"eighty":-0.297799,"marketCap":33359205}],"updateTime":1774853392597},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BTAI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617545487","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2617545487","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617545487?lang=en_us&edition=fundamental","pubTime":"2026-03-05 19:00","pubTimestamp":1772708400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·CPI Card Grp                                    4Q       .65   7:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNQ","AQN","ABM","CIEN","AEYE","AKA","CING","BCIC","BETA","CCEC","ALNT","CTNM","BRLT","ATHM","BLND","COO","AMBQ","OLPX","CRMD","CHRS","ACET","BJ","CTOS","ARQ","BNTX","AMPX","CASY","ALGS","AMTX","BODI","CLAR","COOK","BTAI","ACCO","BVS","FCEL","ANNX","BURL","ALT","ASMB","BBCP","CANG","APYX","ADCT","COST","CRVS","CGEM","CLYM"],"gpt_icon":1},{"id":"2612404776","title":"BioXcel Therapeutics to Host Virtual KOL Roundtable on Acute Agitation in Alzheimer’s Dementia","url":"https://stock-news.laohu8.com/highlight/detail?id=2612404776","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612404776?lang=en_us&edition=fundamental","pubTime":"2026-02-19 20:03","pubTimestamp":1771502592,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics to Host Virtual KOL Roundtable on Acute Agitation in Alzheimer’s Dementia               BioXcel Therapeutics Inc. will host a virtual key opinion leader (KOL) roundtable on the la","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL1Gz5gf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014005.SGD","NDAQ","BTAI","IE00BKPKM429.USD","BK4139","IE00B64PRP62.GBP","BK4585","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","LU2210150020.SGD","BK4588","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014013.SGD","SG9999014039.USD","BK4112"],"gpt_icon":0},{"id":"2610231069","title":"BioXcel Therapeutics Unveils IGALMI At-Home Agitation Treatment Opportunity for Bipolar Disorder and Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2610231069","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610231069?lang=en_us&edition=fundamental","pubTime":"2026-02-12 20:12","pubTimestamp":1770898342,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. has released a presentation highlighting the commercial potential of IGALMI  for the treatment of agitation associated with bipolar disorders and schizophrenia in both institutional and at-home settings. The presentation outlines significant market expansion opportunities, indicating an estimated 86 million addressable at-home agitation episodes annually for bipolar and schizophrenia patients. Clinical trial data from the SERENITY At-Home study demonstrated that IGALMI provided a significant treatment benefit over placebo across varying severity levels of agitation episodes. The safety profile in the at-home setting was consistent with previous findings, with no patients discontinuing due to treatment-emergent adverse events , and no serious adverse events, falls, or syncope reported. Most adverse events were mild, and tolerability remained stable with repeated dosing. The presentation also notes that, currently, there are no approved treatments for agitation ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL40dyTk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2609144495","title":"BioXcel Therapeutics führt neue Bonusvereinbarungen für Führungskräfte ein","url":"https://stock-news.laohu8.com/highlight/detail?id=2609144495","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609144495?lang=en_us&edition=fundamental","pubTime":"2026-02-07 06:01","pubTimestamp":1770415291,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 06, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL3hxVrM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2608879115","title":"Rigel Pharmaceuticals beruft Michael P. Miller in den Vorstand","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879115","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879115?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:05","pubTimestamp":1770123921,"startTime":"0","endTime":"0","summary":"Rigel Pharmaceuticals Inc. hat die Ernennung von Michael P. Miller in den Vorstand bekannt gegeben. Miller verfügt über mehr als vierzig Jahre Erfahrung in kommerziellen und leitenden Positionen in der Biotechnologie- und Pharmaindustrie und ist derzeit auch in den Vorstnden von Puma Biotechnology und BioXcel Therapeutics ttig.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rigel Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on February 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL8rsG3g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RIGL","BK4139","PBYI","BTAI"],"gpt_icon":0},{"id":"2604190299","title":"BUZZ-BioXcel seeks FDA nod for at‑home agitation treatment; shares fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2604190299","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604190299?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:16","pubTimestamp":1768911413,"startTime":"0","endTime":"0","summary":"BUZZ-BioXcel seeks FDA nod for athome agitation treatment; shares fall** Shares of drugmaker BioXcel Therapeutics BTAI.O fall 3.3% to $1.78 premarket** Company says it has asked U.S. FDA to allow athome use of Igalmi for agitation tied to bipolar disorder and schizophrenia** BTAI says Igalmi, an orally dissolving film cleared in 2022 for supervised use, will become the first approved athome option if the FDA agrees** Company filed the request on January 14 via a supplemental application** Agitation is a state of restlessness and intense irritability that can cause sudden outbursts; current treatment options require medical supervision - BTAI** As of last close, shares down ~73% over the past year","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4N3YL11K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2604619081","title":"BioXcel Therapeutics Submits sNDA to FDA for IGALMI Label Expansion to At-Home Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2604619081","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604619081?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:01","pubTimestamp":1768910462,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. has submitted a supplemental New Drug Application  to the U.S. Food and Drug Administration  for IGALMI  sublingual film, seeking label expansion for the acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home  setting. The submission is supported by results from the Phase 3 SERENITY At-Home safety trial, which demonstrated that IGALMI was well-tolerated with a safety profile consistent with its currently approved label. Pending FDA review, potential approval of this label expansion could occur as early as year-end 2026. No other beneficiary organizations were mentioned in connection with this regulatory submission.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL9vkHJs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","LU2210149790.SGD","BK4112","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD","LU0314104364.USD","BK4588","SG9999014013.SGD","BK4139","IE00B3QW5Z07.USD","NDAQ","SG9999014021.USD","SG9999014039.USD","BTAI","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2604190365","title":"BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Igalmi® Label Expansion in the at-Home Setting","url":"https://stock-news.laohu8.com/highlight/detail?id=2604190365","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604190365?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:00","pubTimestamp":1768910402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA93YYSZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2604190352","title":"BioXcel Therapeutics Inc: Submission Timeline Supports Potential Approval of Igalmi Label Expansion as Early as Year-End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2604190352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604190352?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:00","pubTimestamp":1768910402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA93YYSZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2603542869","title":"BioXcel Therapeutics Appoints Mark Pavao as Interim Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542869","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603542869?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:27","pubTimestamp":1768235267,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. has announced that Mark Pavao will join the company as Interim Chief Commercial Officer to support the potential launch of IGALMI for at-home use.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL40Fk6X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2602512882","title":"BioXcel Therapeutics Inc - to Submit Snda This Month for Igalmi at-Home Use - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2602512882","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602512882?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:12","pubTimestamp":1768219978,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2602514938","title":"BioXcel Therapeutics Plans sNDA Submission for IGALMI At-Home Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2602514938","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602514938?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:01","pubTimestamp":1768219282,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. announced that it is on track to submit a supplemental New Drug Application  to the U.S. Food and Drug Administration  seeking approval for IGALMI for at-home use in the acute treatment of agitation associated with bipolar disorders or schizophrenia. The company expects to submit the sNDA this month, with the potential for FDA approval and an at-home launch of IGALMI as early as year-end 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8wvVvK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4588","IE00B3QW5Z07.USD","SG9999014021.USD","BK4112","BK4139","LU2210150020.SGD","BK4585","SG9999014013.SGD","IE00BGHQF748.EUR","BTAI","IE00B64PRP62.GBP","SG9999014039.USD","LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","NDAQ","LU2095319765.USD"],"gpt_icon":0},{"id":"2601870313","title":"BioXcel Therapeutics Plans sNDA Submission Seeking FDA Approval for At-Home Use of IGALMI","url":"https://stock-news.laohu8.com/highlight/detail?id=2601870313","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601870313?lang=en_us&edition=fundamental","pubTime":"2026-01-07 20:01","pubTimestamp":1767787264,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. has announced plans to submit a supplemental New Drug Application  to the U.S. Food and Drug Administration  seeking approval for at-home use of IGALMI  sublingual film for the acute treatment of agitation associated with bipolar disorders or schizophrenia. If approved, IGALMI could become the first FDA-approved at-home treatment option for these conditions as early as 2026. The company is now focused on launch planning to address this unmet need for patients and caregivers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 07, 2026, and is solely responsible for the information contained therei","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL3C0JyH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4588","NDAQ","SG9999014005.SGD","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014039.USD","LU2210150020.SGD","SG9999014021.USD","BK4585","LU0314104364.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BGHQF748.EUR","BTAI","BK4139","SG9999014013.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2601021877","title":"BioXcel Therapeutics Planning to Submit Snda This Month Seeking FDA Approval for at-Home Use of Igalmi®","url":"https://stock-news.laohu8.com/highlight/detail?id=2601021877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601021877?lang=en_us&edition=fundamental","pubTime":"2026-01-07 20:00","pubTimestamp":1767787203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUACTFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2591624400","title":"BioXcel Therapeutics Inc. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2591624400","media":"Reuters","labels":["shareholding","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591624400?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:31","pubTimestamp":1765834268,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. held its annual meeting of stockholders on December 12, 2025. During the meeting, three nominees were elected to the board of directors. Stockholders approved the ratification of Ernst & Young LLP as the company's independent registered public accounting firm for the year ending December 31, 2025. An amendment authorizing a potential reverse stock split at a ratio to be determined by the board was also approved. In addition, authorization for possible adjournments of the annual meeting to solicit additional proxies was granted.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analys","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL6Hxgrx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2583941485","title":"Analysts Conflicted on These Healthcare Names: Bioxcel Therapeutics (BTAI) and Day One Biopharmaceuticals (DAWN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583941485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583941485?lang=en_us&edition=fundamental","pubTime":"2025-11-13 23:30","pubTimestamp":1763047836,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bioxcel Therapeutics (BTAI – Research Report) and Day One Biophar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-bioxcel-therapeutics-btai-and-day-one-biopharmaceuticals-dawn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-bioxcel-therapeutics-btai-and-day-one-biopharmaceuticals-dawn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BTAI","LABU","BK4539","DAWN","HCSG","LU0029874061.USD","LU0128526141.USD","BK4588","BK4581","BK4137","BK4139","XLV","BK4585","XBI"],"gpt_icon":0},{"id":"2582755553","title":"BioXcel Therapeutics Q3 revenue misses analyst expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2582755553","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582755553?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:09","pubTimestamp":1762949389,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Q3 revenue misses analyst expectationsOverviewBioXcel Q3 2025 revenue and net income miss analyst expectationsCompany plans sNDA submission for BXCL501 in Q1 2026BioXcel advances ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2582637396","title":"BRIEF-BioXcel Therapeutics Q3 Basic EPS USD -2.18 Vs. IBES Estimate USD -1.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2582637396","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582637396?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948847,"startTime":"0","endTime":"0","summary":"Nov 12  - BioXcel Therapeutics Q3 net income USD -30.911 million vs. IBES estimate USD -14.1 million.Q3 operating income USD -14.228 million vs. IBES estimate USD -11.4 million. Q3 revenue USD 98 thousand vs. IBES estimate USD 216 thousand","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX4F534C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2582373954","title":"BioXcel Therapeutics Q3 Basic EPS USD -2.18 VS. Ibes Estimate USD -1.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373954?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX4F534C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2582373670","title":"BioXcel Therapeutics Q3 Revenue USD 98 Thousand VS. Ibes Estimate USD 216 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373670","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373670?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX4F534C:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BTAI","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":50,"code":"91000000","status":"200"}]}}